Capstan Therapeutics Funding: $165M Raised, Series A
Capstan Therapeutics is a Biotechnology company based in San Diego, CA. It has raised $165M in total funding. Latest round: Series A.
Capstan Therapeutics funding overview
Capstan Therapeutics is a Biotechnology company based in San Diego, CA. Capstan Therapeutics has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A. Investors on record include Pfizer Ventures, Leaps by Bayer, Novartis Venture Fund, Eli Lilly and Company, Bristol Myers Squibb, OrbiMed and 4 others. 10 distinct backers are named across the disclosed rounds.
Capstan Therapeutics at a glance
Total raised
$165M
Latest round
Series A
Industry
Biotechnology
Headquarters
San Diego, CA
Notable investors
Pfizer Ventures, Leaps by Bayer, Novartis Venture Fund, Eli Lilly and Company, Bristol Myers Squibb, OrbiMed, RA Capital, Vida Ventures
Frequently asked about Capstan Therapeutics funding
How much has Capstan Therapeutics raised?
Capstan Therapeutics has raised $165M in total disclosed funding across the rounds on record.
Who has invested in Capstan Therapeutics?
Pfizer Ventures, Leaps by Bayer, Novartis Venture Fund, Eli Lilly and Company, Bristol Myers Squibb, OrbiMed are named among the investors backing Capstan Therapeutics.
What was the latest Capstan Therapeutics funding round?
The most recent disclosed round is a Series A.
Where is Capstan Therapeutics based?
Capstan Therapeutics is based in San Diego, CA.
What sector does Capstan Therapeutics operate in?
Capstan Therapeutics is tracked under Biotechnology from San Diego, CA, with $165M in disclosed funding.
Capstan Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotechnology companies in San Diego below to benchmark round size and investor mix.
